Professional Documents
Culture Documents
1
9/13/2020
2
9/13/2020
3
9/13/2020
Lumen
Smooth
muscle layer
Smooth muscle
4
9/13/2020
5
9/13/2020
http://www.youtube.com/watch?v=fBn9munofVs
http://www.youtube.com/watch?v=KEME4LtqxsM
http://www.youtube.com/watch?v=KEME4LtqxsM
6
9/13/2020
7
9/13/2020
8
9/13/2020
9
9/13/2020
10
9/13/2020
11
9/13/2020
Stable angina:
predictable and consistent pain that
occurs on exertion and is relieved by
rest. Angina pectoris is said to be stable
when the pattern of its frequency,
intensity, ease of provocation, or
duration does not change over a
several-week period.
12
9/13/2020
Intractable Angina :
13
9/13/2020
Nocturnal Angina
Occurs only at night but not necessarily
during sleep
Angina Decubitus
Chest pain that occurs only while lying
down
Relieved by standing or sitting
Silent ischemia:
objective evidence of ischemia (such
as ECG changes with a stress test),
but patient reports no symptoms.
Associated with diabetes mellitus
and hypertension
14
9/13/2020
ECG.
15
9/13/2020
Diagnostic Studies
History and physical examination
Laboratory data
Hemoglobin and hematocrit level
(Anemia)
Cardiac enzymes (CK2, Troponin I,
troponin T, cholesterol, triglyceride)
ECG (rest and stress)
Coronary angiography
Holter monitor
16
9/13/2020
Exercise Testing
The goal of exercise testing is to induce a
controlled, temporary ischemic state during
clinical and ECG observation
17
9/13/2020
Echocardiography
Visualize cardiac structure and the motion of the valves and chambers
Cardiac Catheterization
18
9/13/2020
Cardiac Catheterization
Transosophageal Echcardiography
Using ultrasound wave to visualize the posterior
aspects of the myocardium
Chest Xray
19
9/13/2020
Cardiac MRI
20
9/13/2020
Medical Management.
Nursing Management.
21
9/13/2020
Management of Angina
Morphine
Oxygen
Nitrate
Aspirin
٤٣
BACK MAIN EXIT INDEX NEXT
1)NITROGLYCERIN
The nitrates remain the mainstay for
treating angina pectoris.
Nitroglycerin (Nitrostat, Nitrol,
Nitrobid IV) is administered to reduce
myocardial oxygen consumption, which
decreases ischemia and relieves pain.
22
9/13/2020
2)BETAADRENERGIC BLOCKING
AGENTS.
Beta blockers such as (Inderal)
and appear to reduce myocardial
oxygen consumption by blocking
the betaadrenergic sympathetic
stimulation to the heart. result is a
reduction in heart rate, blood
pressure, and myocardial
23
9/13/2020
24
9/13/2020
25
9/13/2020
3)CALCIUM CHANNEL
BLOCKING AGENTS.
Reduce the muscle tension in the
coronary arteries, expanding them.
They also slightly relax the heart
muscle, reducing the heart's need
for oxygen and reducing blood
pressure.
26
9/13/2020
27
9/13/2020
OXYGEN ADMINISTRATION.
Oxygen therapy is usually initiated
at the onset of chest pain to increase
the amount of oxygen delivered to
the myocardium and to decrease
pain.
Patients should have an oxygen
saturation (Sp02) level of more than
93%.
28
9/13/2020
Nursing Diagnoses.
1)Altered myocardial tissue
perfusion secondary to CAD, as
evidenced by chest pain (or
equivalent symptoms)
Management:
When a patient senses chest pain,
the nurse should direct the patient
to stop all activities and sit or rest in
bed in a semiFowler's position to
reduce the oxygen requirements of
the ischemic myocardium.
29
9/13/2020
O2 is usually administered at 2 L/
min by nasal canula, even without
evidence of respiratory distress
30
9/13/2020
Nursing Diagnoses.
Anxiety related to fear of death
Management::
Management
31
9/13/2020
Nursing Diagnoses.
Ineffective management of
therapeutic regimen,
Noncompliance, related to failure to
accept necessary lifestyle changes
Management:
Learning to avoid, modify, or adapt
the triggers for anginal pain is
essential.
32
9/13/2020
33
9/13/2020
Expected outcomes:
34
9/13/2020
Avoid excessive caffeine intake which can increase the heart rate&
produce angina
35
9/13/2020
36
9/13/2020
MI is destruction of
myocardial tissue in region of the
heart abruptly deprived of adequate
blood supply because of reduced
coronary blood flow.
37
9/13/2020
38
9/13/2020
39
9/13/2020
40
9/13/2020
41
9/13/2020
42
9/13/2020
↓ urine output.
Crackles.
Peripheral edema.
43
9/13/2020
Troponin.
Myoglobin.
44
9/13/2020
PATIENT HISTORY
The patient history has two parts:
The current complaint of pain.
History of previous illnesses
(include information about the
patient's risk factors for heart
disease) and family health history
( particularly of heart disease).
45
9/13/2020
1)Thrombolytic:
Thrombolytic (IV –directly into the
coronary artery in the cardiac
catheterization laboratory)
46
9/13/2020
47
9/13/2020
Absolute Contraindications.
Active bleeding.
Known bleeding disorder.
History of haemorrhagic stroke.
History of intracranial vessel
malformation
Recent major surgery or trauma.
Uncontrolled hypertension.
Pregnancy
48
9/13/2020
2)Analgesics
The analgesic of choice for acute MI
remains morphine sulphate
administered in intravenous
Not only does morphine reduce pain
and anxiety, but it also reduces preload,
which in turn decreases the workload of
the heart, and relaxes bronchioles to
enhance oxygenation.
Cardiovascular response to
morphine is monitored carefully,
particularly the blood pressure,
which can be lowered, and the
respiratory rate, which can be
depressed.
49
9/13/2020
٩٩
BACK MAIN EXIT INDEX NEXT
Nursing Diagnoses.
Decreased myocardial perfusion
related to reduced coronary blood
flow from coronary thrombus and
atherosclerotic balk .
50
9/13/2020
Management:
Keeping the patient on bed or
chair rest is particularly helpful
in reducing myocardial oxygen
consumption .
Checking skin temperature
and peripheral pulses
frequently is important to
ensure adequate tissue
perfusion.
51
9/13/2020
Nursing Diagnoses
Potential impaired gas exchange
related to fluid overload
Management:
Regular and careful assessment of
respiratory function can help the
nurse detect early signs of
complications associated with the
lungs.
52
9/13/2020
Nursing Diagnoses
Management:
53
9/13/2020
Nursing Diagnoses
Knowledge deficit about postMI
selfcare
Management:
The most effective way to increase the probability that
the patient will comply with a selfcare regimen after
discharge is to provide adequate education about the
disease process and to facilitate the patient's
involvement in a cardiac rehabilitation program.
54
9/13/2020
55